Targeted Cancer Immune Therapy

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Lustgarten, Joseph. (Editor ), Cui, Yan. (Editor ), Li, Shulin. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 2009.
Edición:1st ed. 2009.
Materias:
Acceso en línea:https://doi.org/10.1007/978-1-4419-0170-5
LEADER 02387nam a22003255i 4500
001 978-1-4419-0170-5
005 20191024043517.0
007 cr nn 008mamaa
008 100301s2009 xxu| s |||| 0|eng d
020 |a 9781441901705 
024 7 |a 10.1007/978-1-4419-0170-5  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Targeted Cancer Immune Therapy  |c edited by Joseph Lustgarten, Yan Cui, Shulin Li. 
250 |a 1st ed. 2009. 
260 # # |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2009. 
300 |a XI, 343 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Cytokine Immune Therapy -- Role of IL12 Family in Regulation of Antitumor Immune Response -- IL-18 in Regulation of Antitumor Immune Response and Clinical Application -- Interleukin-21 and Cancer Therapy -- IL-24 in Regulation of Antitumor Immune Response and in Signaling -- IL-28 and IL-29 in Regulation of Antitumor Immune Response and Induction of Tumor Regression -- Passive and Active Tumor Homing Cytokine Therapy -- Cell-based Immune Therapy -- New Strategies to Improve Tumor Cell Vaccine Therapy -- Modification of Dendritic Cells to Enhance Cancer Vaccine Potency -- Dendritic Cell Vaccines for Immunotherapy of Cancer: Challenges in Clinical Trials -- A "Toll Bridge" for Tumor-Specific T Cells -- Engineering Adult Stem Cells for Cancer Immunotherapy -- Animal Models for Evaluating Immune Responses of Human Effector Cells In Vivo -- Targeted Immune Therapy -- CD40 Stimulation and Antitumor Effects -- Immunocytokines: A Novel Approach to Cancer Immune Therapy -- Immune Escape: Role of Indoleamine 2,3-Dioxygenase in Tumor Tolerance -- Adoptive Transfer of T-Bodies: Toward an Effective Cancer Immunotherapy -- Targeting Toll-Like Receptor for the Induction of Immune and Antitumor Responses -- Manipulating TNF Receptors to Enhance Tumor Immunity for the Treatment of Cancer. 
650 0 |a Cancer research. 
650 0 |a Pharmacology. 
650 1 4 |a Cancer Research. 
650 2 4 |a Pharmacology/Toxicology. 
700 1 |a Lustgarten, Joseph.  |e editor. 
700 1 |a Cui, Yan.  |e editor. 
700 1 |a Li, Shulin.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
856 4 0 |u https://doi.org/10.1007/978-1-4419-0170-5